In this video, Motley Fool contributors Jason Hall and Tyler Crowe discuss why Comfort Systems USA (NYSE: FIX) is one of the biggest beneficiaries of the explosive demand for infrastructure related to artificial intelligence.
In this video, Motley Fool contributors Jason Hall and Tyler Crowe discuss why Comfort Systems USA (NYSE: FIX) is one of the biggest beneficiaries of the explosive demand for infrastructure related to artificial intelligence.
The OPT100 camera comes in three retro designs. | Image: Kakaku Following the popularity of the Kodak Charmera , it was inevitable that other retro-inspired digital toy cameras would start popping up. While the Charmera's design was inspired by the '80s single-use Kodak Fling camera, the OPT100 Neo Film crams a basic digital camera into a 35mm film roll that comes inside a plastic canister and a ...
The OPT100 camera comes in three retro designs. | Image: Kakaku Following the popularity of the Kodak Charmera , it was inevitable that other retro-inspired digital toy cameras would start popping up. While the Charmera's design was inspired by the '80s single-use Kodak Fling camera, the OPT100 Neo Film crams a basic digital camera into a 35mm film roll that comes inside a plastic canister and a small box with a matching aesthetic. Priced at 5,940 yen, or just shy of $40, the OPT100 is currently only available in Japan. If you can't resist cute digital cameras with terrible specs, you can find them on eBay for a significant markup, but Amazon Japan also appears to stock them. The OPT100's 1-megapixel sen … Read the full story at The Verge.
Rivian stock surged on Friday morning after the EV-maker reported strong delivery guidance for the year, as it ramps up for the release of its R2 vehicle which the company said is on track for the second quarter of this year.
Rivian stock surged on Friday morning after the EV-maker reported strong delivery guidance for the year, as it ramps up for the release of its R2 vehicle which the company said is on track for the second quarter of this year.
We Are/DigitalVision via Getty Images Introduction: Execution is fine, Valuation isn’t Main Street Capital Corporation ( MAIN ) has always been a quality company. Its NAV per share has been growing for 13 consecutive quarters. Q4 2025 NAV is estimated to be around $33.29–$33.37, up roughly 1.5–1.8% quarter over quarter. Full-year annualized return estimates on equity exceed 17%, according to manag...
We Are/DigitalVision via Getty Images Introduction: Execution is fine, Valuation isn’t Main Street Capital Corporation ( MAIN ) has always been a quality company. Its NAV per share has been growing for 13 consecutive quarters. Q4 2025 NAV is estimated to be around $33.29–$33.37, up roughly 1.5–1.8% quarter over quarter. Full-year annualized return estimates on equity exceed 17%, according to management . One more positive: distributable net investment income easily covers the regular dividend. On the other side of this story, MAIN shares trade around $61–62, so roughly 1.8-1.9x NAV. That’s around 40-50% higher than the BDC sector median and also well above MAIN’s own long-term average price-to-book multiple. In other words, this is premium pricing for a quality company that leaves no margin of error in execution. So, the market assumes that MAIN will be able to reliably deliver income, just not a lot of price appreciation. Returns will come mostly from dividends, and even modest multiple compressions will hurt. Now, MAIN’s estimated forward dividend yield comes to 6.9-7.0%, with an annual payout of ~$4.30 per share. This goes to support the yield and is paid monthly. Compared to the broad financial sector, this yield is attractive enough. However, it is below MAIN’s own historical average. This means today’s investors are willing to pay more for a lower yield only because it has proven to be durable. Earnings estimates, on the other hand, are flat to slightly negative overall, according to street consensus. Estimated EPS growth through 2027 is close to zero. That again means that future returns are likely primarily dividend-driven. This brings us to the MAIN problem: this BDC can keep on performing well. It can originate first-lien loans, realize profits, issue equity at a premium to NAV, and pay dependable monthly dividends. It can do all these positives—but they are all baked into its current price. So it will only be able to deliver mid-single-digit total returns...
bluestocking/E+ via Getty Images Summary We favor equities over credit heading into 2026—tight spreads and AI-related leverage create asymmetric risk in corporate bonds, while equities benefit from a supportive cyclical backdrop and elevated capital returns. Above-consensus US growth should persist as the tariff drag fades, fiscal support from the One Big Beautiful Bill Act (OBBBA) flows through, ...
bluestocking/E+ via Getty Images Summary We favor equities over credit heading into 2026—tight spreads and AI-related leverage create asymmetric risk in corporate bonds, while equities benefit from a supportive cyclical backdrop and elevated capital returns. Above-consensus US growth should persist as the tariff drag fades, fiscal support from the One Big Beautiful Bill Act (OBBBA) flows through, and the Fed eases toward short-term rates of 3.00% to 3.25%. AI is pivoting from infrastructure buildout to monetization and value creation—we’re positioning to capture this transition through hyperscalers (where strong gross margins cushion capex) and AI users capturing productivity gains. We believe the cyclical backdrop should dominate valuation concerns—real long rates support current multiples, elevated capital returns make equities an effective inflation hedge, and underlying business quality justifies premium pricing for growth. Our sector positioning balances offense and defense—financials benefit from yield curve steepening and regulatory tailwinds; healthcare provides a hedge against technology, given record negative correlations with momentum. Commentary continues page 2… Performance data quoted represents past performance, which is no guarantee of future results. Current performance may be lower or higher than the performance quoted. Please refer to Important Risk Information. The principal value and return of an investment will fluctuate so that your shares, when redeemed, may be worth more or less than their original cost. Performance reflected at NAV does not include the Fund's maximum front-end sales load of 4.75%. Had it been included, the Fund's return would have been lower. You can obtain performance data current to the most recent month end by visiting www.calamos.com. The funds' gross expense ratios as of the prospectus dated 2/28/2025 are as follows: A Shares 1.05%, C Shares 1.80%, I Shares 0.80% and R6 Shares 0.73%. Class I shares ( CGIIX ) are offere...
格隆汇2月13日|据两位知情人士透露,美联储预计将任命兰德尔·奎恩(Randall Guynn)为新任监管事务主任,这位与银行业关系深厚的华尔街资深人士将执掌行业监管大权。奎恩曾为Davis Polk & Wardwell律师事务所合伙人,代表过多家美国大型银行。他将接替在美联储任职逾三十年后于去年7月宣布退休的迈克尔·吉布森。自2025年5月起,奎恩一直担任美联储理事兼监管事务副主席鲍曼的顾问。...
格隆汇2月13日|据两位知情人士透露,美联储预计将任命兰德尔·奎恩(Randall Guynn)为新任监管事务主任,这位与银行业关系深厚的华尔街资深人士将执掌行业监管大权。奎恩曾为Davis Polk & Wardwell律师事务所合伙人,代表过多家美国大型银行。他将接替在美联储任职逾三十年后于去年7月宣布退休的迈克尔·吉布森。自2025年5月起,奎恩一直担任美联储理事兼监管事务副主席鲍曼的顾问。据消息人士称,奎恩的任命计划仍须经美联储七人理事会投票表决。目前未能确定此次闭门投票的具体时间。其履新后将继续向鲍曼汇报工作。选择奎恩担任监管事务主任将标志着美联储人事安排的重大转变,至少自1977年以来,该职位一直由长期任职的美联储内部职员担任。
Catherine Delahaye/DigitalVision via Getty Images Article Thesis The current earnings season is well underway, and many retail companies are about to report their earnings results in the next couple of weeks. In this article, I will take a look at the industry to see how consumers are doing, what trends are in place, and what investors can expect from the upcoming reports. The Retail Industry In T...
Catherine Delahaye/DigitalVision via Getty Images Article Thesis The current earnings season is well underway, and many retail companies are about to report their earnings results in the next couple of weeks. In this article, I will take a look at the industry to see how consumers are doing, what trends are in place, and what investors can expect from the upcoming reports. The Retail Industry In The Current Macro Environment Of course, not all companies in a single industry are performing the same, as there are always companies that fare better due to a better strategy, stronger brands, better pricing, more efficient operations, and so on. Still, there are often at least some similarities among companies from the same industry, which is why taking a look at the macro items that impact a specific industry makes a lot of sense, I believe. When it comes to the retail industry, macro items of note are consumer sentiment, employment, disposable income, etc. Looking at the most recent consumer sentiment reading, we see the following: Data by YCharts According to the Consumer Sentiment Index in the US, consumer sentiment is a little worse today compared to one year ago, although it is better than last fall and in spring, when both markets and consumers worried a lot about tariffs. In the last couple of months, consumer sentiment has been improving, which is good . M omentum is positive, and if that trend continues, we could see substantially better consumer sentiment not too far from now. Looking at employment, we see the following: Data by YCharts Over the last half year or so, employment has been reliably positive . N ew jobs are being created in the United States. While there were some ups and downs, with better employment change numbers in some months and less new job creation in others, employment clearly keeps expanding, which should naturally be good for both economic growth in general and also for the retail industry. After all, more people having jobs means more p...
(RTTNews) - The Labor Department released a highly anticipated report on Friday showing consumer prices in the U.S. increased by slightly less than expected in the month of January.
(RTTNews) - The Labor Department released a highly anticipated report on Friday showing consumer prices in the U.S. increased by slightly less than expected in the month of January.
iQoncept/iStock via Getty Images Amid heightened market volatility, the healthcare sector ( XLV ) has become a battleground for short sellers, with biotechnology and healthcare services emerging as the primary targets. At the center of this bearish siege is Hims & Hers ( HIMS ), which led the industry with a staggering short interest as of January 31, 2026. Hims & Hers Health ( HIMS ) leads the be...
iQoncept/iStock via Getty Images Amid heightened market volatility, the healthcare sector ( XLV ) has become a battleground for short sellers, with biotechnology and healthcare services emerging as the primary targets. At the center of this bearish siege is Hims & Hers ( HIMS ), which led the industry with a staggering short interest as of January 31, 2026. Hims & Hers Health ( HIMS ) leads the bearish list with a 32.95% short interest following the launch of their $49/month oral semaglutide . Investors are betting that the FDA will soon tighten restrictions on compounded weight-loss drugs, now that branded versions like Wegovy and Zepbound are back in full supply. At the same time, CRISPR Therapeutics ( CRSP ) is the second-most shorted stock in the sector at 22.81%. In contrast, some healthcare giants like BrightSpring Health Services ( BTSGU ) and Regencell Bioscience ( RGC ) have very low short interest at 0.10% and 0.19%, respectively. They are joined by industry leaders Medline ( MDLN ), Eli Lilly ( LLY ), and Johnson & Johnson ( JNJ ), all of which maintain short interest levels well below 1%, because they are seen as much safer bets during uncertain times. Healthcare stocks are outperforming the broader market so far this year. The Health Care Select Sector SPDR® Fund ETF (NYSEARCA: XLV ), which tracks the health care sector and holds a weightage of 12.12% in the S&P 500 index, has gained 0.78% in 2026. This stands in contrast to the S&P 500's overall 0.19% decline, signaling investor preference for healthcare over growth sectors. Here are the top 5 most shorted mid- to mega-cap healthcare stocks (as a % of shares outstanding) as of January 30: Hims & Hers Health ( HIMS ) - Health Care Services sector, short interest 32.95% CRISPR Therapeutics ( CRSP ) - Biotechnology, short interest 22.81% Viking Therapeutics ( VKTX ) - Biotechnology, short interest 21.75% Soleno Therapeutics ( SLNO ) - Biotechnology, short interest 21.36% TransMedics Group ( TMDX ) - Healt...
Extending his England men’s team contract until 2028 means increased stability and a less relentless form of pressure Thomas Tuchel was supposed to be here for a good time, not a long time. It was win or bust when he signed up to become England’s head coach in October 2024. The target was clear – lead the side to glory at the 2026 World Cup – and it came with an acceptance that the German was noth...
Extending his England men’s team contract until 2028 means increased stability and a less relentless form of pressure Thomas Tuchel was supposed to be here for a good time, not a long time. It was win or bust when he signed up to become England’s head coach in October 2024. The target was clear – lead the side to glory at the 2026 World Cup – and it came with an acceptance that the German was nothing more than a very expensive gun for hire. An 18-month deal, which began on 1 January 2025, saw to that. Tuchel talked about it giving him focus. He said it streamlined the role. “It’s a little bit of a step into the unknown for me,” he said. Tuchel would have to adapt. He loves being out on the training pitch, working with his players, honing their understanding of his tactics. Wouldn’t he get bored during the long months without a game? Wouldn’t he get itchy feet as soon as he saw a job open up at a big club? Continue reading...